Clinical application of anticoagulation therapy after simultaneous pancreas and kidney transplantation: a single-center observational cohort study / 中华器官移植杂志
Chinese Journal of Organ Transplantation
; (12): 663-668, 2021.
Article
en Zh
| WPRIM
| ID: wpr-911697
Biblioteca responsable:
WPRO
ABSTRACT
Objective:To explore the clinical efficacy of aspirin plus low molecule heparin for pancreatic thrombosis during simultaneous pancreas and kidney transplantation (SPK).Methods:A total of 129 patients aged 18 years or higher underwent SPK between September 2016 and March 2020.They were divided retrospectively into two groups of aspirin ( n=60) and heparin ( n=69) according to different anticoagulant regimens.The aspirin group received only aspirin 100 mg/d at Day 1 post-operation.The heparin group received subcutaneous injection of enoxaparin 2 000 AxaIU daily for 7 days and followed by aspirin and clopidogrel.Outcomes and complication rates were compared between two groups. Results:All operations were successful without any mortality.In aspirin group, there were 5 cases of pancreatic thrombosis and one patient underwent pancreatectomy.There was no pancreatic thrombosis in heparin group ( P=0.014). There were 8 cases of intestinal anastomotic bleeding in aspirin group and 19 cases in heparin group.Statistically significant inter-group difference existed ( P=0.048). However, no significant inter-group difference existed in delayed recovery or rejection. Conclusions:Heparin anticoagulation can significantly lower the incidence of pancreatic thrombosis after SPK.Despite a higher incidence of intestinal anastomotic bleeding, no serious complication occurs after conservative meaures.
Texto completo:
1
Base de datos:
WPRIM
Tipo de estudio:
Etiology_studies
/
Observational_studies
Idioma:
Zh
Revista:
Chinese Journal of Organ Transplantation
Año:
2021
Tipo del documento:
Article